PubMed

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.

Koh ES, Tran TH, Heydarian M, Sachs RK, Tsang RW, Brenner DJ, Pintilie M, Xu T, Chung J, Paul N, Hodgson DC.

Radiat Oncol. 2007 Mar 15;2:13.PMID: 17362522 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.

Hodgson DC, Koh ES, Tran TH, Heydarian M, Tsang R, Pintilie M, Xu T, Huang L, Sachs RK, Brenner DJ.

Cancer. 2007 Dec 1;110(11):2576-86.PMID: 17941006 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.

Vordermark D, Seufert I, Schwab F, Kölbl O, Kung M, Angermann C, Flentje M.

Radiat Oncol. 2006 Apr 20;1:10.PMID: 16722610 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. Epub 2009 Apr 20.PMID: 19386423 [PubMed - indexed for MEDLINE]Related citations

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):208-18.PMID: 15093918 [PubMed - indexed for MEDLINE]Related citations

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R.

J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7.PMID: 7563187 [PubMed - indexed for MEDLINE]Related citations

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. Epub 2009 Aug 10.PMID: 19667275 [PubMed - indexed for MEDLINE]Related citations

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K; Children's Cancer Group.

J Clin Oncol. 2002 Sep 15;20(18):3765-71.PMID: 12228196 [PubMed - indexed for MEDLINE]Related citations

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E.

J Natl Cancer Inst. 2002 Feb 6;94(3):182-92.PMID: 11830608 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.PMID: 12837833 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):36-43.PMID: 12504034 [PubMed - indexed for MEDLINE]Related citations

A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.

Willner J, Jost A, Baier K, Flentje M.

Strahlenther Onkol. 2003 Aug;179(8):548-56.PMID: 14509954 [PubMed - indexed for MEDLINE]Related citations

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.

Salloum E, Doria R, Schubert W, Zelterman D, Holford T, Roberts KB, Farber LR, Kiehl RK, Cardinale J, Cooper DL.

J Clin Oncol. 1996 Sep;14(9):2435-43.PMID: 8823321 [PubMed - indexed for MEDLINE]Related citations

[Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions]

Glanzmann C, Lütolf UM.

Strahlenther Onkol. 1993 Oct;169(10):570-83. Review. German. PMID: 8235981 [PubMed - indexed for MEDLINE]Related citations

Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.

Weber DC, Peguret N, Dipasquale G, Cozzi L.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1578-86.PMID: 19596171 [PubMed - indexed for MEDLINE]Related citations

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.

J Clin Oncol. 1994 Feb;12(2):312-25.PMID: 8113838 [PubMed - indexed for MEDLINE]Related citations

Predicted Risk of Radiation-Induced Cancers after Involved Field and Involved Node Radiotherapy with or without Intensity Modulation for Early-Stage Hodgkin Lymphoma in Female Patients.

Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR.

Int J Radiat Oncol Biol Phys. 2010 Aug 26. [Epub ahead of print]PMID: 20800383 [PubMed - as supplied by publisher]Related citations

Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.

Eich HT, Haverkamp U, Engert A, Kocher M, Skripnitchenko R, Brillant C, Sehlen S, Dühmke E, Diehl V, Müller RP.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):860-5. Epub 2005 May 31.PMID: 15925455 [PubMed - indexed for MEDLINE]Related citations

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.PMID: 8611686 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Lung cancer risk and radiation dose among women treated for breast cancer.

Inskip PD, Stovall M, Flannery JT.

J Natl Cancer Inst. 1994 Jul 6;86(13):983-8.PMID: 8007020 [PubMed - indexed for MEDLINE]Related citations